Faivre-Finn C, Spigel DR, Senan S, Langer C, et al. Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC). Lung Cancer 2021;151:30-38.
PMID: 33285469